Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Study of CS-3150 in Japanese Patients with Essential Hypertension
NCT02722265Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of esaxerenone in essential hypertension, sponsored by Daiichi Sankyo Co., Ltd.. Started Mar 2016; status: completed.
02
Drugs
esaxerenone
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT02722265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02722265.